- October 4, 2022
- Newsletter
- 617-430-5616
Menu
ADVERTISEMENT
ADVERTISEMENT
Brand Name :
Aricept ODT, Aricept
Synonyms :
Class :
Acetylcholinesterase Inhibitors
No drug interaction found for donepezil (Rx) and .
bradycardia-Causing Agents may enhance the bradycardic effect of Ceritinib
bradycardia-Causing Agents may enhance the bradycardic effect of ponesimod
may increase the bradycardic effect of bradycardia-causing agents
may have an increased constipating effect when combined with clozapine
may have an increased anticholinergic effect when combined with glycopyrrolate
may have an increased bradycardic effect when combined with fingolimod
may have an increased bradycardic effect when combined with ponesimod
may have an increased bradycardic effect when combined with siponimod
they increase the toxicity of opioid agonists
they increase the toxicity of opioid agonists
they increase the toxicity of opioid agonists
they increase the toxicity of opioid agonists
bradycardia causing agents increase the arrhythmia-causing effect of fexinidazole
may increase the bradycardia effect
may decrease the therapeutic effects
may have an increased anticholinergic effect when combined with cimetropium
may have an increased constipating effect when combined with eluxadoline
may have an increased anticholinergic effect when combined with anticholinergic agents
may increase the anticholinergic effect of Anticholinergic Agents
anticholinergic agents increase the ulcer-producing effect of potassium citrate
may increase the anticholinergic effect of each other when combined
may have an increased anticholinergic effect when combined with anticholinergic agents
it may reduce the therapeutic effect of anticholinergic agents
it may reduce the therapeutic effect of anticholinergic agents
it may reduce the therapeutic effect of anticholinergic agents
it may reduce the therapeutic effect of anticholinergic agents
it may reduce the therapeutic effect of anticholinergic agents
It may increase the neurotoxic effect of Antipsychotic Agents
It may increase the neurotoxic effect of Antipsychotic Agents
It may increase the neurotoxic effect of Antipsychotic Agents
It may increase the neurotoxic effect of Antipsychotic Agents
It may increase the neurotoxic effect of Antipsychotic Agents
It may increase the neurotoxic effect of Antipsychotic Agents
It may increase the neurotoxic effect of Antipsychotic Agents
It may increase the neurotoxic effect of Antipsychotic Agents
It may increase the neurotoxic effect of Antipsychotic Agents
It may increase the neurotoxic effect of Antipsychotic Agents
It may increase the neurotoxic effect of Antipsychotic Agents
It may increase the neurotoxic effect of Antipsychotic Agents
It may increase the neurotoxic effect of Antipsychotic Agents
It may increase the neurotoxic effect of Antipsychotic Agents
it may increase the bradycardic effect of Beta-Blockers
it may increase the bradycardic effect of Beta-Blockers
it may increase the bradycardic effect of Beta-Blockers
it may increase the bradycardic effect on other Bradycardia-Causing Agents
it may enhance the risk of adverse effects of Cholinergic Agonists
it may enhance the risk of adverse effects of Cholinergic Agonists
it may enhance the risk of adverse effects of Cholinergic Agonists
it may enhance the risk of adverse effects of Cholinergic Agonists
it may enhance the risk of adverse effects of Cholinergic Agonists
it may enhance the risk of adverse effects of Acetylcholinesterase Inhibitors
it may enhance the risk of adverse effects of Acetylcholinesterase Inhibitors
it may enhance the risk of adverse effects of Acetylcholinesterase Inhibitors
it may enhance the risk of adverse effects of Acetylcholinesterase Inhibitors
it may enhance the risk of adverse effects of Acetylcholinesterase Inhibitors
it may reduce the neuromuscular blocking effect of Neuromuscular Blocking Agents
it may reduce the neuromuscular blocking effect of Neuromuscular Blocking Agents
it may reduce the neuromuscular blocking effect of Neuromuscular Blocking Agents
it may reduce the neuromuscular blocking effect of Neuromuscular Blocking Agents
it may reduce the neuromuscular blocking effect of Neuromuscular Blocking Agents
acetylcholinesterase Inhibitors reduce the therapeutic effect of anticholinergic Agents
acetylcholinesterase Inhibitors reduce the therapeutic effect of anticholinergic Agents
acetylcholinesterase Inhibitors reduce the therapeutic effect of anticholinergic Agents
acetylcholinesterase Inhibitors reduce the therapeutic effect of anticholinergic Agents
acetylcholinesterase Inhibitors reduce the therapeutic effect of anticholinergic Agents
acetylcholinesterase inhibitors may enhance the adverse/toxic effect of cholinergic Agonists
acetylcholinesterase inhibitors may enhance the adverse/toxic effect of cholinergic Agonists
acetylcholinesterase inhibitors may enhance the adverse/toxic effect of cholinergic Agonists
acetylcholinesterase inhibitors may enhance the adverse/toxic effect of cholinergic Agonists
acetylcholinesterase inhibitors may enhance the adverse/toxic effect of cholinergic Agonists
acetylcholinesterase Inhibitors May enhance the bradycardic effect of beta-Blockers
acetylcholinesterase Inhibitors May enhance the bradycardic effect of beta-Blockers
acetylcholinesterase Inhibitors May enhance the bradycardic effect of beta-Blockers
acetylcholinesterase Inhibitors May enhance the bradycardic effect of beta-Blockers
acetylcholinesterase Inhibitors May enhance the bradycardic effect of beta-Blockers
may enhance the neurotoxic (central) effect of antipsychotic agents
may enhance the neurotoxic (central) effect of antipsychotic agents
may enhance the neurotoxic (central) effect of antipsychotic agents
may enhance the neurotoxic (central) effect of antipsychotic agents
may enhance the neurotoxic (central) effect of antipsychotic agents
may enhance the neurotoxic (central) effect of antipsychotic agents
may enhance the neurotoxic (central) effect of antipsychotic agents
may enhance the neurotoxic (central) effect of antipsychotic agents
may enhance the neurotoxic (central) effect of antipsychotic agents
may enhance the neurotoxic (central) effect of antipsychotic agents
may enhance the neurotoxic (central) effect of antipsychotic agents
may enhance the neurotoxic (central) effect of antipsychotic agents
may enhance the neurotoxic (central) effect of antipsychotic agents
may enhance the neurotoxic (central) effect of antipsychotic agents
may enhance the neurotoxic (central) effect of antipsychotic agents
corticosteroids may enhance the adverse/toxic effect of acetylcholinesterase Inhibitors
corticosteroids may enhance the adverse/toxic effect of acetylcholinesterase Inhibitors
corticosteroids may enhance the adverse/toxic effect of acetylcholinesterase Inhibitors
corticosteroids may enhance the adverse/toxic effect of acetylcholinesterase Inhibitors
corticosteroids may enhance the adverse/toxic effect of acetylcholinesterase Inhibitors
may enhance the neurotoxic (central) effect of antipsychotic agents
may enhance the neurotoxic (central) effect of antipsychotic agents
may enhance the neurotoxic (central) effect of antipsychotic agents
may enhance the neurotoxic (central) effect of antipsychotic agents
may enhance the neurotoxic (central) effect of antipsychotic agents
may enhance the neurotoxic (central) effect of antipsychotic agents
may enhance the neurotoxic (central) effect of antipsychotic agents
may enhance the neurotoxic (central) effect of antipsychotic agents
may enhance the neurotoxic (central) effect of antipsychotic agents
may enhance the neurotoxic (central) effect of antipsychotic agents
may enhance the neurotoxic (central) effect of antipsychotic agents
may enhance the neurotoxic (central) effect of antipsychotic agents
may enhance the neurotoxic (central) effect of antipsychotic agents
may increase the bradycardic effect of beta-blockers
may increase the bradycardic effect of beta-blockers
may increase the bradycardic effect of beta-blockers
may increase the bradycardic effect of beta-blockers
may increase the bradycardic effect of beta-blockers
may reduce the effect of neuromuscular-blocking agents
may reduce the effect of neuromuscular-blocking agents
may reduce the effect of neuromuscular-blocking agents
may reduce the effect of neuromuscular-blocking agents
may reduce the effect of neuromuscular-blocking agents
may enhance the effect of other bradycardia agents
may enhance the effect of other bradycardia agents
may enhance the effect of other bradycardia agents
may enhance the effect of other bradycardia agents
may enhance the effect of other bradycardia agents
may enhance the neurotoxic effect of antipsychotic agents
may enhance the neurotoxic effect of antipsychotic agents
may enhance the neurotoxic effect of antipsychotic agents
may enhance the neurotoxic effect of antipsychotic agents
may enhance the neurotoxic effect of antipsychotic agents
may enhance the neurotoxic effect of antipsychotic agents
may enhance the neurotoxic effect of antipsychotic agents
may enhance the neurotoxic effect of antipsychotic agents
may enhance the neurotoxic effect of antipsychotic agents
may enhance the neurotoxic effect of antipsychotic agents
may enhance the neurotoxic effect of antipsychotic agents
may enhance the neurotoxic effect of antipsychotic agents
may enhance the neurotoxic effect of antipsychotic agents
may enhance the neurotoxic effect of antipsychotic agents
may enhance the neurotoxic effect of antipsychotic agents
may enhance the neurotoxic effect of antipsychotic agents
may enhance the neurotoxic effect of antipsychotic agents
may enhance the neurotoxic effect of antipsychotic agents
may decrease the therapeutic effect when combined with anticholinergic agents
may decrease the therapeutic effect when combined with anticholinergic agents
may decrease the therapeutic effect when combined with anticholinergic agents
may decrease the therapeutic effect when combined with anticholinergic agents
may decrease the therapeutic effect when combined with anticholinergic agents
may have an increased neurotoxic effect when combined with antipsychotic agents
may have an increased neurotoxic effect when combined with antipsychotic agents
may have an increased neurotoxic effect when combined with antipsychotic agents
may have an increased neurotoxic effect when combined with antipsychotic agents
may have an increased neurotoxic effect when combined with antipsychotic agents
may increase the effect of beta-blockers
may increase the effect of beta-blockers
may increase the effect of beta-blockers
may increase the effect of beta-blockers
may increase the effect of beta-blockers
may increase the effect of antipsychotic agents
may increase the effect of antipsychotic agents
may increase the effect of antipsychotic agents
may increase the effect of antipsychotic agents
may increase the effect of antipsychotic agents
may increase the effect of antipsychotic agents
may increase the effect of antipsychotic agents
may increase the effect of antipsychotic agents
may increase the effect of antipsychotic agents
may increase the effect of antipsychotic agents
may increase the effect of antipsychotic agents
may increase the effect of antipsychotic agents
may increase the effect of antipsychotic agents
may increase the effect of antipsychotic agents
may increase the effect of antipsychotic agents
may increase the effect of antipsychotic agents
may increase the effect of antipsychotic agents
may increase the effect of antipsychotic agents
may increase the effect of antipsychotic agents
may increase the effect of antipsychotic agents
may increase the effect of antipsychotic agents
may increase the effect of antipsychotic agents
may increase the effect of antipsychotic agents
may decrease the neuromuscular-blocking effect when combined with neuromuscular-blocking agents
may decrease the neuromuscular-blocking effect when combined with neuromuscular-blocking agents
may decrease the neuromuscular-blocking effect when combined with neuromuscular-blocking agents
may decrease the neuromuscular-blocking effect when combined with neuromuscular-blocking agents
may decrease the neuromuscular-blocking effect when combined with neuromuscular-blocking agents
reduce the therapeutic effect
reduce the therapeutic effect
reduce the therapeutic effect
reduce the therapeutic effect
reduce the therapeutic effect
may increase the neurotoxic effect
may increase the neurotoxic effect
may increase the neurotoxic effect
may increase the neurotoxic effect
may increase the neurotoxic effect
may increase the neurotoxic effect
may increase the neurotoxic effect
may increase the neurotoxic effect
may increase the neurotoxic effect
may increase the neurotoxic effect
may increase the neurotoxic effect
may increase the neurotoxic effect
may increase the neurotoxic effect
may increase the neurotoxic effect
may increase the neurotoxic effect
may increase the neurotoxic effect
may increase the neurotoxic effect
may increase the neurotoxic effect
may increase the neurotoxic effect
may increase the neurotoxic effect
may increase the neurotoxic effect
may increase the neurotoxic effect
may increase the neurotoxic effect
may increase the neurotoxic effect
may have an increased neurotoxic effect when combined with antipsychotic agents
may have an increased neurotoxic effect when combined with antipsychotic agents
may have an increased neurotoxic effect when combined with antipsychotic agents
may have an increased neurotoxic effect when combined with antipsychotic agents
may have an increased neurotoxic effect when combined with antipsychotic agents
may increase the neurotoxic effect
may increase the neurotoxic effect
may increase the neurotoxic effect
may increase the neurotoxic effect
may increase the bradycardic effect
may increase the bradycardic effect
may increase the bradycardic effect
may increase the bradycardic effect
may increase the bradycardic effect
may increase the bradycardic effect
may increase the bradycardic effect
may increase the bradycardic effect
may increase the bradycardic effect
may increase the bradycardic effect
may have an increased bradycardic effect when combined with beta-blockers
may have an increased bradycardic effect when combined with beta-blockers
may have an increased bradycardic effect when combined with beta-blockers
may have an increased bradycardic effect when combined with beta-blockers
may have an increased bradycardic effect when combined with beta-blockers
May diminish the therapeutic effect of Anticholinergic Agents
may reduce the therapeutic effect of anticholinergic agents
may reduce the therapeutic effect of anticholinergic agents
may reduce the therapeutic effect of anticholinergic agents
may reduce the therapeutic effect of anticholinergic agents
may reduce the therapeutic effect of anticholinergic agents
hydrocodone/chlorpheniramine/pseudoephedrine
may decrease the therapeutic effect of anticholinergic agents
may decrease the therapeutic effect
may increase the immunosuppressive effect of corticosteroids
may enhance the effect of other bradycardia agents
may enhance the effect of other bradycardia agents
may enhance the effect of other bradycardia agents
may enhance the effect of other bradycardia agents
may enhance the effect of other bradycardia agents
bradycardia-causing agents increase the efficacy of ivabradine
may increase the toxic effect
may diminish the therapeutic effect of acetylcholinesterase Inhibitors
may diminish the therapeutic effect of acetylcholinesterase Inhibitors
may diminish the therapeutic effect of acetylcholinesterase Inhibitors
may diminish the therapeutic effect of acetylcholinesterase Inhibitors
may diminish the therapeutic effect of acetylcholinesterase Inhibitors
may decrease the therapeutic effect of dipyradimole
may increase the adverse effect of corticosteroids
may increase the toxic effect of corticosteroids
may enhance the serum concentration of anticholinergic agents
may enhance the serum concentration of anticholinergic agents
may enhance the serum concentration of anticholinergic agents
may enhance the serum concentration of anticholinergic agents
may increase the bradycardic effect of beta blockers
may decrease the therapeutic effect of anticholinergic agents
acrivastine and pseudoephedrine
may decrease the therapeutic effect of anticholinergic agents
may increase the bradycardic effect of beta blockers
may increase the bradycardic effect of bradycardia-causing agents
may decrease the therapeutic effect when combined with anticholinergic agents
may decrease the therapeutic effect when combined with anticholinergic agents
may enhance the risk of adverse effect of acetylcholinesterase inhibitors
may enhance the risk of adverse effect of acetylcholinesterase inhibitors
may enhance the risk of adverse effect of acetylcholinesterase inhibitors
may enhance the risk of adverse effect of acetylcholinesterase inhibitors
may enhance the risk of adverse effect of acetylcholinesterase inhibitors
may enhance the risk of adverse effect of acetylcholinesterase inhibitors
may enhance the risk of adverse effect of acetylcholinesterase inhibitors
may enhance the risk of adverse effect of acetylcholinesterase inhibitors
may enhance the risk of adverse effect of acetylcholinesterase inhibitors
may enhance the risk of adverse effect of acetylcholinesterase inhibitors
may enhance the risk of adverse effect of acetylcholinesterase inhibitors
may enhance the risk of adverse effect of acetylcholinesterase inhibitors
may enhance the risk of adverse effect of acetylcholinesterase inhibitors
may enhance the risk of adverse effect of acetylcholinesterase inhibitors
may enhance the risk of adverse effect of acetylcholinesterase inhibitors
may enhance the risk of adverse effect of acetylcholinesterase inhibitors
may enhance the risk of adverse effect of acetylcholinesterase inhibitors
may enhance the risk of adverse effect of acetylcholinesterase inhibitors
may enhance the risk of adverse effect of acetylcholinesterase inhibitors
may enhance the risk of adverse effect of acetylcholinesterase inhibitors
may enhance the risk of adverse effect of acetylcholinesterase inhibitors
may enhance the risk of adverse effect of acetylcholinesterase inhibitors
may enhance the risk of adverse effect of acetylcholinesterase inhibitors
may enhance the risk of adverse effect of acetylcholinesterase inhibitors
may enhance the risk of adverse effect of acetylcholinesterase inhibitors
may enhance the risk of adverse effect of acetylcholinesterase inhibitors
may decrease the therapeutic effect of Anticholinergic Agents
may enhance the bradycardic effect of beta blockers
may enhance the bradycardic effect of bradycardia-causing agents
may increase the toxic effect of cholinergic agonists
may decrease the therapeutic effect of anticholinergic agents
may decrease the therapeutic effect of Anticholinergic Agents
may increase the toxic effect of nonsteroidal anti-inflammatory agents
may have an increased anticholinergic effect when combined with anticholinergic agents
may enhance the anticholinergic effect of Anticholinergic agents
may increase the anticholinergic effect of anticholinergic agents
may increase the hypotensive effect of blood pressure lowering agents
may decrease the therapeutic effect of Anti-cholinergic Agent
may increase the toxic effect of other Anticholinergic Agents
may diminish the absorption when combined with nitroglycerin
may increase the neurotoxic effect of Antipsychotic Agents
may have an increasingly adverse effect when combined with glucagon
anticholinergic agents increase the toxicity of topiramate
may decrease the therapeutic effect of Anticholinergic Agents
may increases the adverse effect of Opioid Agonists
buprenorphine,long-acting injection
may increases the adverse effect of Opioid Agonists.
may diminish the effects of pharmacodynamic antagonism
glycopyrrolate inhaled and formoterol
may diminish the effects through pharmacodynamic antagonism
anticholinergic agents decrease the efficacy of secretin
Dosage Forms & Strengths
Tablet
5mg
10mg
23mg
Tablet-oral disintegrating
5mg
10mg
Mild/moderate: 5 mg orally daily, may increase up to10 mg after 4-6 weeks Moderate/severe: 5 mg/day orally, increase up to 10 mg/day after 4-6 weeks; and after 3 months increase up to 23 mg/day Administration Take at bedtime and dissolve the drug under the tongue and follow with water
Dose Adjustments
Dose Modification Renal Impairment: Not Available Hepatic Impairment: Not Available
Safety and efficacy not established
Adverse drug reactions:
Frequency Defined
>10%
Erythema
Papules
Headache
1-10%
Muscle spasms
Insomnia
Abdominal pain
Application site dermatitis
Constipation
Diarrhea
Application site pain
Dizziness
Abnormal dreams
Skin laceration
<1%
Edema
Post marketing Reports:
Hemolytic anemia
Heart block
QTc prolongation
Abdominal pain
Cholecystitis
Hepatitis
pancreatitis
Hyponatremia
Pregnancy warnings:
Pregnancy category: C
Breastfeeding warnings:
crosses into breast milk- Unknown
Pregnancy Categories:
Patient Information Leaflet
Generic Name: donepezil transdermal
Why do we use donepezil transdermal?
donepezil belongs to the class of Acetylcholinesterase Inhibitors, which helps to treat Alzheimer’s disease and Dementia
ADVERTISEMENT
Brand Name :
Aricept ODT, Aricept
Synonyms :
Class :
Acetylcholinesterase Inhibitors
Dosage Forms & Strengths
Tablet
5mg
10mg
23mg
Tablet-oral disintegrating
5mg
10mg
Mild/moderate: 5 mg orally daily, may increase up to10 mg after 4-6 weeks Moderate/severe: 5 mg/day orally, increase up to 10 mg/day after 4-6 weeks; and after 3 months increase up to 23 mg/day Administration Take at bedtime and dissolve the drug under the tongue and follow with water
Dose Adjustments
Dose Modification Renal Impairment: Not Available Hepatic Impairment: Not Available
Safety and efficacy not established